165 related articles for article (PubMed ID: 7187069)
1. [Effect of treatment with encorton and cytostatics on cellular immunity in patients with systemic lupus erythematosus].
Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz T; Wierzchowska E
Reumatologia; 1982; 20(3-4):137-42. PubMed ID: 7187069
[No Abstract] [Full Text] [Related]
2. [Effect of treatment with enkorton and cytostatics on selected immunologic indicators in patients with systemic lupus erythematosus].
Małdykowa H; Chwalińska-Sadowska H; Grabowska A; Dratwianka B; Abgarowicz-Miłkowska T; Jedryka-Góral A; Swierczyńska Z; Rdułtowska H; Luft S; Rogozińska E
Reumatologia; 1982; 20(1-2):7-14. PubMed ID: 7163667
[No Abstract] [Full Text] [Related]
3. Effect of plasmapheresis on cellular immunity abnormalities in patients with systemic lupus erythematosus.
Bonomini V; Vangelista A; Frascà GM; Nanni-Costa A; Borgnino LC
Clin Nephrol; 1984 Sep; 22(3):121-6. PubMed ID: 6237815
[TBL] [Abstract][Full Text] [Related]
4. A preliminary study on T lymphocyte subsets in systemic lupus erythematosus.
Yang JL; Chen PZ; Dong Y; Tang FL; Zhang NZ
Chin Med J (Engl); 1988 Sep; 101(9):665-70. PubMed ID: 2976662
[No Abstract] [Full Text] [Related]
5. [Interferon therapy effects on activation of T-lymphocytes in patients with systemic lupus erythematosus].
Stanislav ML; Balabanova RM; Nikonova MF; Litvina MM; Iarilin AA
Ter Arkh; 2000; 72(5):44-9. PubMed ID: 11109620
[TBL] [Abstract][Full Text] [Related]
6. [Clinical significance of a study of T and B lymphocytes in children with systemic lupus erythematosus and chronic juvenile arthritis].
Mesihović H; Tomić B; Lojpur V; Cengić H; Terzić R
Med Arh; 1985; 39(1):7-10. PubMed ID: 3917046
[No Abstract] [Full Text] [Related]
7. Plasmapheresis in systemic lupus erythematosus: effects on cellular immunity.
Vangelista A; Frascà GM; Nanni-Costa A; Bonomini V
Trans Am Soc Artif Intern Organs; 1983; 29():749-53. PubMed ID: 6608818
[No Abstract] [Full Text] [Related]
8. [The effect of steroid therapy on cellular reactions in vivo in patients with cutaneous and systemic forms of erythematosus].
Bukvić-Knor T
Med Arh; 1989; 43(2-3):137-40. PubMed ID: 2628666
[TBL] [Abstract][Full Text] [Related]
9. [Lymphocyte transformation during immunosuppressive therapy of lupus erythematosus visceralis].
Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
Z Gesamte Inn Med; 1969 Jan; 24(1):Suppl:152-4. PubMed ID: 5402572
[No Abstract] [Full Text] [Related]
10. [Transformation of lymphocytes during immunosuppressive therapy in lupus erythematosus visceralis].
Heine KM; Klatt R; Stobbe H; Apostoloff E; Jendrusch C
Z Gesamte Inn Med; 1969 May; 24(10):152-4. PubMed ID: 5812420
[No Abstract] [Full Text] [Related]
11. [Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations].
Fuks A; Carballal G; Manni JA
Medicina (B Aires); 1979; 39(3):289-97. PubMed ID: 514050
[No Abstract] [Full Text] [Related]
12. [The leukocyte migration test in the presence of DNA during disseminated lupus erythematosus].
Moulias R; Goust JM; Reinert P; Devillechabrolle A; Muller Berat CN; Hereman C; Godeau P
Nouv Presse Med; 1972 May; 1(21):1403-7. PubMed ID: 4113927
[No Abstract] [Full Text] [Related]
13. Overview of treatment of lupus nephropathy.
Coggins CH
Am J Kidney Dis; 1982 Jul; 2(1 Suppl 1):197-200. PubMed ID: 7102668
[No Abstract] [Full Text] [Related]
14. [Lymphocyte population in systemic lupus erythematosus].
Del Pozo Pérez MA; Prieto Valtueña J; González Guilabert MI; Velasco Alonso R
Rev Clin Esp; 1975 Mar; 136(6):527-30. PubMed ID: 1079620
[No Abstract] [Full Text] [Related]
15. Impaired responsiveness of lymphocytes in patients with systemic lupus erythematosus.
Suciu-Foca N; Buda JA; Thiem T; Reemtsma K
Clin Exp Immunol; 1974 Nov; 18(3):295-301. PubMed ID: 4283364
[TBL] [Abstract][Full Text] [Related]
16. The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship.
Wouters CH; Diegenant C; Ceuppens JL; Degreef H; Stevens EA
Br J Dermatol; 2004 Apr; 150(4):693-700. PubMed ID: 15099365
[TBL] [Abstract][Full Text] [Related]
17. [Systemic lupus erythematosus. Etiopathogenesis and immunosuppressive therapy].
Clément F
Schweiz Med Wochenschr; 1973 Oct; 103(40):1369-77. PubMed ID: 4755631
[No Abstract] [Full Text] [Related]
18. [Interrelationships of cellular and humoral immunity indices in systemic lupus erythematosus].
Matveĭkov GP; Dosin IuM; Kaliia ES; Koshelev VK; Nazarov IuM
Ter Arkh; 1982; 54(12):44-8. PubMed ID: 6984235
[No Abstract] [Full Text] [Related]
19. [T-lymphocyte values in peripheral blood in systemic lupus erythematosus and similar nosological entities (progressive systemic sclerosis, rheumatoid arthritis, and mixed connective tissue disease) (author's transl)].
Rovenský J; Jarosková L; Zitnan D; Pekábek J; Svejcar J
Cas Lek Cesk; 1982 Mar; 121(12):370-4. PubMed ID: 6979391
[No Abstract] [Full Text] [Related]
20. [Effect of levamisole (Decaris) on various immunologic parameters in patients with systemic lupus erythematosus].
Gandzha IM; Sakharchuk VM; Lysenko GI
Ter Arkh; 1981; 53(7):121-4. PubMed ID: 6457406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
